MedPath

Comparison of Insulin glargine U-300 vs Insulin degludec using FreeStyle Libre Pro:randomised crossover study

Not Applicable
Conditions
diabetes
Registration Number
JPRN-UMIN000026780
Lead Sponsor
Murakami Memorial Hosupital
Brief Summary

Glucose levels less than 70 mg/dL were not significantly different between the two insulin treatments. Nocturnal hypoglycemia with Gla300 was significantly lower than that with Deg treatment. Incidence of nocturnal hypoglycemia with Deg treatment was associated with the concomitant use of metformin.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
24
Inclusion Criteria

Not provided

Exclusion Criteria

Severe renal dysfunction Judged to be unsuitable for participation for medical reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<70mg/dL hypoglycemia
Secondary Outcome Measures
NameTimeMethod
CV-value mean glucose level,SD M-value,MODD, <54mg/dL hypogliycemia
© Copyright 2025. All Rights Reserved by MedPath